Pharming Group (PHARM): Directorate Change Leiden, The Nether...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	11
Posts	1480
Boards Moderated	0
Alias Born	05/07/2008

plumo

Re: None

Friday, 08/03/2012 4:04:30 PM

Friday, August 03, 2012 4:04:30 PM

Directorate Change

Leiden, The Netherlands, August 3, 2012.Biotech company Pharming Group NV (?Pharming? or ?the Company?) (NYSE Euronext: PHARM) today announces that Karl Keegan, Chief Financial Officer, is leaving the Company in order to pursue a position based in the UK. Karl will step down from his role as CFO and resign from the Board of Management and the Company as of end of August. In view of the recently announced downsizing of the organization and Karl?s upcoming departure, the future size of the Board of Management will also be evaluated. Following Karl?s departure, his responsibilities as CFO will be assigned to Sijmen de Vries, Chief Executive Officer.

Sijmen de Vries, Pharming CEO, said: ?On behalf of Pharming I would like to thank Karl for his hard work and significant contribution since joining the Company two years ago, particularly his efforts in securing financing for the Company in the face of challenging funding conditions for biotechs. We wish Karl all the best in his future endeavours.?